CVRx COO granted stock options and RSUs

CVRx, Inc. chief operating officer Brent Binkowski reported equity awards on February 27, 2026.

Rhea-AI Filing Summary

CVRx, Inc. chief operating officer Brent Binkowski reported equity awards on February 27, 2026. He received 23,000 stock options with an exercise price of $0.00 per share and a separate grant of 15,000 shares of common stock, both classified as awards rather than open-market purchases.

The 15,000-share common stock grant consists of restricted stock units that vest in four equal annual installments of 25% on each anniversary of the grant date. The 23,000-stock-option award vests as to 25% of the shares on February 27, 2027, with the remaining shares vesting in equal monthly installments over the following 36 months. After these transactions, Binkowski directly owned 31,600 shares of common stock, according to the filing.

Insider Trade Summary

Grant/Award: 38,000 shares

Grant/Award 2 txns

Insider Binkowski Brent

Role CHIEF OPERATING OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	23,000	$0.00	$0.00
Grant/Award	Common Stock	15,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 23,000 contracts (Direct); Common Stock — 31,600 shares (Direct)

Footnotes (2)

1. F1. Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.
2. F2. Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did CVRX COO Brent Binkowski report on this Form 4?

Brent Binkowski reported receiving a 23,000-share stock option grant and 15,000 shares of common stock as equity awards. Both were granted at a $0.00 price per share, indicating compensation grants rather than open-market purchases.

How do Brent Binkowski’s new CVRX restricted stock units vest?

The 15,000 CVRX common shares are structured as restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. This creates four equal vesting installments over four years, subject to continued service or applicable conditions.

What is the vesting schedule for Brent Binkowski’s 23,000 CVRX stock options?

The 23,000 CVRX stock options vest as to 25% of the shares on February 27, 2027. The remaining 75% vest in equal monthly installments, 1/48th of the shares per month, over the following 36 months, aligning vesting with ongoing tenure.

Did Brent Binkowski buy CVRX shares on the open market in this Form 4?

No, the Form 4 shows award-type acquisitions rather than open-market purchases. Both the 23,000 stock options and 15,000 common shares are reported under code A as grants or awards, with a $0.00 transaction price per share.

How many CVRX common shares does Brent Binkowski own after these transactions?

After the equity awards, Brent Binkowski is reported as directly owning 31,600 shares of CVRX common stock. This post-transaction figure reflects the addition of the 15,000-share restricted stock grant to his prior directly held share balance.

Are the new CVRX equity awards to Brent Binkowski subject to continued vesting?

Yes, both awards are subject to time-based vesting. The 15,000 restricted shares vest 25% annually, and the 23,000 options vest 25% after one year then monthly. Actual retention depends on ongoing service and any plan or employment terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 06:00 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Binkowski Brent

(Last) (First) (Middle)

9201 WEST BROADWAY AVENUE

SUITE 650

(Street)

MINNEAPOLIS MN 55445

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF OPERATING OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		15,000(1)	A	$0	31,600	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.16	02/27/2026		A		23,000		(2)	02/26/2036	Common Stock	23,000	$0	23,000	D

Explanation of Responses:

1. Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.

2. Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

	/s/ Amy C. Seidel, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.